Pfizer Company Profile (NYSE:PFE)

About Pfizer

Pfizer logoPfizer Inc. is a research-based global biopharmaceutical company. The Company is engaged in discovering, developing and manufacturing of healthcare products. Its portfolio includes medicines, vaccines and medical devices, as well as consumer healthcare products. Its products include Prevnar/Prevenar 13, Lyrica, Enbrel, Lipitor, Viagra, Sutent, BeneFIX, Genotropin, ReFacto, Xyntha and Enbrel. Its commercial operations consist of two businesses: Innovative Products business and Established Products business. The Innovative Products business consists of two segments: the Global Innovative Pharmaceutical segment (GIP) and the Global Vaccines, Oncology and Consumer Healthcare segment (VOC). The Established Products business consists of the Global Established Pharmaceutical segment (GEP). Its research focuses on six areas, which include immunology and inflammation, cardiovascular and metabolic diseases, oncology, vaccines, neuroscience and pain, and rare diseases.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: Pharmaceuticals
  • Exchange: NYSE
  • Symbol: PFE
  • CUSIP: 71708110
Key Metrics:
  • Previous Close: $33.83
  • 50 Day Moving Average: $34.5969
  • 200 Day Moving Average: $34.0216
  • 52-Week Range: $28.25 - $37.39
  • Trailing P/E Ratio: 29.9380
  • Foreward P/E Ratio: 12.88
  • P/E Growth: 2.1100
  • Market Cap: $204.84B
  • Outstanding Shares: 6,065,652,000
  • Beta: 0.87
Profitability:
  • Net Margins: 14.88%
  • Return on Equity: 23.37%
  • Return on Assets: 8.99%
Debt:
  • Debt-to-Equity Ratio: 0.48%
  • Current Ratio: 1.37%
  • Quick Ratio: 1.13%
Additional Links:
Companies Related to Pfizer:

Analyst Ratings

Consensus Ratings for Pfizer (NYSE:PFE) (?)
Ratings Breakdown: 9 Hold Ratings, 14 Buy Ratings
Consensus Rating:Buy (Score: 2.61)
Consensus Price Target: $38.85 (14.30% upside)

Analysts' Ratings History for Pfizer (NYSE:PFE)
Show:
DateFirmActionRatingPrice TargetDetails
9/27/2016Bank of America Corp.Reiterated RatingBuy$40.00View Rating Details
9/26/2016Sanford C. BernsteinReiterated RatingOutperformView Rating Details
9/13/2016Jefferies GroupLower Price TargetBuy$40.00 -> $39.00View Rating Details
8/28/2016ArgusReiterated RatingBuy$39.00View Rating Details
8/23/2016Piper Jaffray Cos.Set Price TargetBuy$54.00View Rating Details
8/23/2016BMO Capital MarketsReiterated RatingOutperform$40.00View Rating Details
8/22/2016Credit Suisse Group AGReiterated RatingOutperform$40.00View Rating Details
8/18/2016Deutsche Bank AGReiterated RatingBuy$44.00View Rating Details
8/3/2016JPMorgan Chase & Co.Set Price TargetBuy$40.00View Rating Details
8/3/2016Citigroup Inc.Reiterated RatingNeutral$37.00View Rating Details
8/2/2016Barclays PLCReiterated RatingEqual Weight$34.00View Rating Details
5/17/2016Morgan StanleyReiterated RatingHold$36.00View Rating Details
5/12/2016Berenberg BankInitiated CoverageHold$38.00View Rating Details
5/9/2016Goldman Sachs Group Inc.Set Price TargetNeutral$37.00View Rating Details
5/4/2016Independent Research GmbHSet Price TargetNeutral$37.00View Rating Details
5/4/2016Societe GeneraleSet Price TargetNeutral$34.00View Rating Details
5/2/2016Leerink SwannLower Price TargetMarket Perform$37.00 -> $34.70View Rating Details
4/12/2016S&P Equity ResearchReiterated RatingBuyView Rating Details
2/16/2016SunTrust Banks Inc.Lower Price TargetNeutral$37.00 -> $33.00View Rating Details
1/26/2016Nord/LBReiterated RatingBuyView Rating Details
1/5/2016Atlantic SecuritiesReiterated RatingBuy$39.00View Rating Details
12/2/2015Cowen and CompanyReiterated RatingBuy$43.00View Rating Details
11/24/2015Evercore ISIReiterated RatingBuy$38.00View Rating Details
(Data available from 9/28/2014 forward)

Earnings

Earnings History for Pfizer (NYSE:PFE)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/25/2016        
8/2/2016Q216$0.62$0.64$13.01 billion$13.10 billionViewN/AView Earnings Details
5/3/2016Q116$0.55$0.67$12.00 billion$13.00 billionViewN/AView Earnings Details
2/2/2016Q415$0.52$0.53$13.57 billion$14.05 billionViewN/AView Earnings Details
10/27/2015Q315$0.51$0.60$11.56 billion$12.10 billionViewListenView Earnings Details
7/28/2015Q215$0.52$0.56$11.39 billion$11.00 billionViewListenView Earnings Details
4/28/2015Q115$0.49$0.51$10.79 billion$10.86 billionViewN/AView Earnings Details
1/27/2015Q414$0.53$0.54$12.94 billion$13.10 billionViewN/AView Earnings Details
10/28/2014Q314$0.55$0.57$12.24 billion$12.40 billionViewN/AView Earnings Details
7/29/2014Q214$0.57$0.58$12.49 billion$12.80 billionViewN/AView Earnings Details
5/5/2014Q114$0.56$0.57$12.07 billion$11.35 millionViewN/AView Earnings Details
1/27/2014Q413$0.52$0.56$13.35 billion$13.56 billionViewN/AView Earnings Details
10/29/2013Q313$0.56$0.58$12.69 billion$12.64 billionViewN/AView Earnings Details
7/30/2013Q2 2013$0.55$0.56$13.02 billion$12.97 billionViewListenView Earnings Details
4/30/2013Q1 2013$0.55$0.54$14.10 billion$13.50 billionViewListenView Earnings Details
1/29/2013Q4 2012$0.44$0.47$14.40 billion$15.10 billionViewListenView Earnings Details
11/1/2012Q312$0.53$0.53$14.64 billion$14.00 billionViewN/AView Earnings Details
7/31/2012$0.54$0.62ViewN/AView Earnings Details
5/1/2012$0.57$0.58ViewN/AView Earnings Details
1/31/2012$0.47$0.50ViewN/AView Earnings Details
11/1/2011$0.55$0.62ViewN/AView Earnings Details
8/2/2011$0.59$0.60ViewN/AView Earnings Details
5/3/2011$0.59$0.60ViewN/AView Earnings Details
2/1/2011$0.46$0.47ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Pfizer (NYSE:PFE)
Current Year EPS Consensus Estimate: $2.46 EPS
Next Year EPS Consensus Estimate: $2.64 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163$0.54$0.56$0.55
Q2 20164$0.56$0.63$0.61
Q3 20163$0.57$0.62$0.60
Q4 20163$0.51$0.58$0.55
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for Pfizer (NYSE:PFE)
Annual Dividend:$1.20
Dividend Yield:3.53%
Dividend Growth:8.40% (3 Year Average)
Payout Ratio:95.24% (Based on Trailing 12 Months of Earnings)
48.78% (Based on Current Year Consensus EPS Estimate)
45.45% (Based on Next Year Consensus EPS Estimate)
Track Record:6 Years of Consecutive Dividend Growth

Dividend History for Pfizer (NYSE:PFE)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
9/23/2016quarterly$0.303.5%11/8/201611/11/201612/1/2016
6/23/2016quarterly$0.303.53%8/3/20168/5/20169/1/2016
4/28/2016quarterly$0.303.67%5/11/20165/13/20166/1/2016
12/14/2015quarterly$0.303.72%2/3/20162/5/20163/2/2016
9/25/2015quarterly$0.283.63%11/4/201511/6/201512/1/2015
6/25/2015quarterly$0.283.3%8/5/20158/7/20159/2/2015
4/23/2015quarterly$0.283.18%5/6/20155/8/20156/2/2015
12/15/2014quarterly$0.283.65%2/4/20152/6/20153/3/2015
10/23/2014quarterly$0.263.57%11/5/201411/7/201412/2/2014
6/26/2014quarterly$0.263.51%7/30/20148/1/20149/3/2014
4/25/2014quarterly$0.263.38%5/7/20145/9/20146/3/2014
12/16/2013quarterly$0.263.45%2/5/20142/7/20143/4/2014
10/24/2013quarterly$0.243.14%11/6/201311/8/201312/3/2013
6/27/2013quarterly$0.243.43%7/31/20138/2/20139/4/2013
4/25/2013quarterly$0.243.19%5/8/20135/10/20136/4/2013
12/17/2012quarterly$0.243.74%1/30/20132/1/20133/5/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Pfizer (NYSE:PFE)
Insider Ownership Percentage: 0.07%
Institutional Ownership Percentage: 69.65%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/26/2016Frank A DamelioEVPSell100,000$34.49$3,449,000.00View SEC Filing  
5/24/2016Loretta V CangialosiVPSell86,000$33.97$2,921,420.00View SEC Filing  
5/11/2016Laurie J OlsonEVPSell4,700$33.50$157,450.00View SEC Filing  
5/10/2016Frank A DamelioEVPSell192,000$33.66$6,462,720.00View SEC Filing  
5/10/2016John D YoungInsiderSell41,700$33.53$1,398,201.00View SEC Filing  
5/9/2016Anthony J MaddalunaEVPSell8,950$33.75$302,062.50View SEC Filing  
5/9/2016Ian C ReadCEOSell275,000$33.80$9,295,000.00View SEC Filing  
5/5/2016Sally SusmanEVPSell76,116$33.75$2,568,915.00View SEC Filing  
5/4/2016Douglas M LanklerEVPSell29,700$33.69$1,000,593.00View SEC Filing  
5/4/2016Mikael DolstenInsiderSell67,588$33.46$2,261,494.48View SEC Filing  
5/3/2016Frank A DamelioEVPSell87,079$33.65$2,930,208.35View SEC Filing  
10/6/2015Pfizer Incmajor shareholderBuy714,285$7.00$4,999,995.00View SEC Filing  
6/11/2015Laurie J OlsonEVPSell26,000$34.39$894,140.00View SEC Filing  
3/12/2015Sally SusmanEVPSell46,179$34.00$1,570,086.00View SEC Filing  
2/13/2015Loretta V CangialosiVPSell104,000$34.73$3,611,920.00View SEC Filing  
2/12/2015Anthony J MaddalunaEVPSell9,000$34.85$313,650.00View SEC Filing  
2/11/2015Frank A DamelioEVPSell14,800$34.30$507,640.00View SEC Filing  
2/10/2015Anthony J MaddalunaEVPSell9,000$33.78$304,020.00View SEC Filing  
12/8/2014Anthony J MaddalunaEVPSell6,500$32.00$208,000.00View SEC Filing  
11/10/2014Charles H HillEVPSell8,285$30.18$250,041.30View SEC Filing  
11/7/2014John D YoungInsiderSell21,600$29.89$645,624.00View SEC Filing  
10/29/2014Anthony J MaddalunaEVPSell2,425$29.56$71,683.00View SEC Filing  
6/12/2014Laurie J OlsonEVPSell36,275$29.53$1,071,200.75View SEC Filing  
6/2/2014Geno J GermanoInsiderSell30,000$29.68$890,400.00View SEC Filing  
3/17/2014John YoungInsiderSell9,000$31.38$282,420.00View SEC Filing  
3/4/2014Loretta CangialosiVPSell102,943$32.05$3,299,323.15View SEC Filing  
3/4/2014Mikael DolstenInsiderSell35,789$32.58$1,166,005.62View SEC Filing  
3/4/2014Sally SusmanEVPSell67,585$32.59$2,202,595.15View SEC Filing  
1/13/2014Frank DamelioEVPSell131,810$30.82$4,062,384.20View SEC Filing  
11/1/2013Anthony J MaddalunaEVPSell43,500$31.02$1,349,370.00View SEC Filing  
11/1/2013Loretta V CangialosiVPSell10,000$31.20$312,000.00View SEC Filing  
10/28/2013Ian C ReadCEOSell338,000$30.57$10,332,660.00View SEC Filing  
9/16/2013Freda Lewis-HallEVPSell38,461$28.70$1,103,830.70View SEC Filing  
7/31/2013Charles H HillEVPSell96,500$29.64$2,860,260.00View SEC Filing  
7/31/2013Loretta V CangialosiVPSell14,688$29.63$435,205.44View SEC Filing  
5/15/2013Amy W SchulmanEVPSell70,000$29.36$2,055,200.00View SEC Filing  
5/15/2013Ian C ReadCEOSell69,900$29.39$2,054,361.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Pfizer (NYSE:PFE)
DateHeadline
thecountrycaller.com logoPfizer Inc. (PFE): Fitch Affirms Ratings Over Decision To Scrap The Split (NYSE:PFE)
www.thecountrycaller.com - September 28 at 11:48 AM
thestreet.com logoBattle of the Pharmaceutical Bigwigs: GlaxoSmithKline vs. Pfizer (NYSE:PFE)
www.thestreet.com - September 28 at 11:48 AM
insidermonkey.com logoWhy Oracle, SolarCity, Tesla and Two Other Stocks Are Making Headlines Today (NYSE:PFE)
www.insidermonkey.com - September 28 at 11:48 AM
feeds.reuters.com logoBRIEF-Pfizer to showcase progress of broad-based oncology portfolio at ESMO 2016 Congress (NYSE:PFE)
feeds.reuters.com - September 28 at 6:40 AM
investors.com logoPfizer can’t do without essential health, or innovation (NYSE:PFE)
www.proactiveinvestors.com - September 27 at 6:37 PM
nasdaq.com logoPfizer (PFE) to Stay Together as a Single Company After All (NYSE:PFE)
www.nasdaq.com - September 27 at 6:37 PM
feeds.benzinga.com logoMarkets In Monotone Mode Despite Post-Debate Rally (NYSE:PFE)
feeds.benzinga.com - September 27 at 3:16 PM
feeds.reuters.com logoBRIEF-Fitch says Pfizer's scrapped split decision will not affect ratings (NYSE:PFE)
feeds.reuters.com - September 27 at 11:27 AM
News IconMix Cap Volatile Mover: Pfizer Inc. (NYSE:PFE), ITC Holdings (NYSE:ITC), MGT Capital Investments (NYSE:MGT) - Street Wise Report (press release) (blog) (NYSE:PFE)
streetwisereport.com - September 27 at 11:19 AM
News IconPfizer Inc. (NYSE:PFE) & Idera Pharmaceuticals Inc (NASDAQ:IDRA) Stocks to Keep Your Eyes on - Money News (NYSE:PFE)
www.newsismoney.com - September 27 at 11:19 AM
thecountrycaller.com logoHere's Why Pfizer Inc. (PFE) Won't Split Essential Health & Innovative Health - TCC (NYSE:PFE)
www.thecountrycaller.com - September 27 at 11:19 AM
investors.com logoYou Can't Ignore This News on Pfizer Inc. (PFE) Stock - Income Investors (NYSE:PFE)
www.incomeinvestors.com - September 27 at 11:19 AM
marketrealist.com logoPharmaceuticals Deal with End of Key Cystic Fibrosis Study (NYSE:PFE)
marketrealist.com - September 27 at 11:19 AM
fool.com logoIs This Pfizer's Next Mega-Blockbuster Cancer Drug? (NYSE:PFE)
www.fool.com - September 27 at 10:25 AM
fool.com logoPfizer's Latest Immunotherapy Deal Could Be Great News for This Tiny Company (NYSE:PFE)
www.fool.com - September 27 at 8:59 AM
finance.yahoo.com logoPfizer decides against split-up; more deals seen likely (NYSE:PFE)
in.finance.yahoo.com - September 26 at 6:48 PM
etfdailynews.com logoPfizer Shares Retreat After Company Decides Against Break-Up (NYSE:PFE)
etfdailynews.com - September 26 at 6:48 PM
streetinsider.com logoPfizer (PFE) Won't Pursue Split (NYSE:PFE)
www.streetinsider.com - September 26 at 6:48 PM
reuters.com logoPfizer abandons plan to split into two companies (NYSE:PFE)
www.reuters.com - September 26 at 6:48 PM
sg.finance.yahoo.com logoHow the Dow Jones industrial average fared on Monday (NYSE:PFE)
sg.finance.yahoo.com - September 26 at 6:48 PM
barrons.com logo[$$] Pfizer Won't Split and Neither Should Investors (NYSE:PFE)
www.barrons.com - September 26 at 6:48 PM
feeds.reuters.com logoPfizer walks away from $118 billion AstraZeneca takeover fight (NYSE:PFE)
feeds.reuters.com - September 26 at 5:46 PM
abcnews.go.com logoUS Stocks Slide as Banks Tumble on Deutsche Bank Worries (NYSE:PFE)
abcnews.go.com - September 26 at 5:27 PM
nytimes.com logoPfizer Remains Whole, but the Option to Split Could Return (NYSE:PFE)
www.nytimes.com - September 26 at 2:25 PM
feeds.reuters.com logoBRIEF-Moody's changes outlook on Pfizer's to stable from negative, affirms ratings (NYSE:PFE)
feeds.reuters.com - September 26 at 1:40 PM
feeds.reuters.com logoUPDATE 3-Pfizer abandons plan to split into two companies (NYSE:PFE)
feeds.reuters.com - September 26 at 12:18 PM
News IconPfizer Inc. (NYSE:PFE) Revealed That Waiting Period Under Hart-Scott-Rodino Antitrust Improvements Act- Cellcom ... - Seneca Globe (NYSE:PFE)
www.senecaglobe.com - September 26 at 11:35 AM
News IconScorching Hot Biotech Stocks Tape: Pfizer Inc. (PFE), Sarepta Therapeutics, Inc. (SRPT) - The Independent Republic (NYSE:PFE)
theindependentrepublic.com - September 26 at 11:35 AM
schaeffersresearch.com logoBuzz Stocks: Pfizer Inc., GW Pharmaceuticals PLC, and Chemtura Corp - Schaeffers Research (blog) (NYSE:PFE)
www.schaeffersresearch.com - September 26 at 11:35 AM
reuters.com logoPfizer abandons plan to split into two companies - Reuters (NYSE:PFE)
www.reuters.com - September 26 at 11:35 AM
thestreet.com logoStocks Fall as Health Care Slumps Ahead of Presidential Debate (NYSE:PFE)
www.thestreet.com - September 26 at 11:35 AM
finance.yahoo.com logoUS STOCKS-Wall St drops as Pfizer falls; presidential debate eyed (NYSE:PFE)
finance.yahoo.com - September 26 at 11:35 AM
wsj.com logo[$$] Pfizer Throws Out Plan to Split Into Two Companies (NYSE:PFE)
www.wsj.com - September 26 at 11:35 AM
blogs.barrons.com logoPfizer: Split Decision (NYSE:PFE)
blogs.barrons.com - September 26 at 11:35 AM
News IconPfizer Decides Against the Split (NYSE:PFE)
feedproxy.google.com - September 26 at 11:12 AM
News IconWhy Pfizer, Netflix, Amazon.com, Deutsche Bank, and Cal-Maine Foods Are Trending (NYSE:PFE)
feedproxy.google.com - September 26 at 10:49 AM
News IconThe long-anticipated Pfizer split-up won't happen, CEO says - FiercePharma (NYSE:PFE)
www.fiercepharma.com - September 26 at 9:46 AM
usatoday.com logoPfizer eschews proposal to split into two (NYSE:PFE)
rssfeeds.usatoday.com - September 26 at 9:28 AM
feeds.reuters.com logoUPDATE 2-Pfizer abandons plan to split into two companies (NYSE:PFE)
feeds.reuters.com - September 26 at 9:06 AM
seekingalpha.com logoPfizer opts to remain one company; shares off 1% premarket (NYSE:PFE)
seekingalpha.com - September 26 at 8:47 AM
feeds.reuters.com logoPfizer abandons plan to split into two (NYSE:PFE)
feeds.reuters.com - September 26 at 8:47 AM
feeds.benzinga.com logoUPDATE: Pfizer Says 2 Divisions Will Remain Separately Managed Within Single Company (NYSE:PFE)
feeds.benzinga.com - September 26 at 8:27 AM
feeds.benzinga.com logoPfizer Decides Against Splitting Innovative And Essential Health, Will Remain One Company (NYSE:PFE)
feeds.benzinga.com - September 26 at 8:27 AM
finance.yahoo.com logoPfizer won’t split, ending years of speculation (NYSE:PFE)
finance.yahoo.com - September 26 at 8:27 AM
marketwatch.com logoPfizer will not split into two publicly traded companies; shares slip premarket (NYSE:PFE)
feeds.marketwatch.com - September 26 at 8:27 AM
seekingalpha.com logoPfizer: A Risky Pick Now - Seeking Alpha (NYSE:PFE)
seekingalpha.com - September 23 at 11:30 AM
News IconHit List News Buzzer: Pfizer Inc. (NYSE:PFE), AbbVie Inc. (NYSE:ABBV), Denison Mines (NYSE:DNN) - Seneca Globe (NYSE:PFE)
www.senecaglobe.com - September 23 at 11:30 AM
News IconPfizer Inc. (NYSE:PFE) To Report September 2016 Results - The Voice Registrar (NYSE:PFE)
voiceregistrar.com - September 23 at 11:30 AM
finance.yahoo.com logoLundbeck says Alzheimer's late-stage study fails (NYSE:PFE)
finance.yahoo.com - September 22 at 6:25 PM
seekingalpha.com logoPfizer: A Risky Pick Now (NYSE:PFE)
seekingalpha.com - September 22 at 11:33 AM

Social

Pfizer (NYSE:PFE) Chart for Wednesday, September, 28, 2016


Last Updated on 9/28/2016 by MarketBeat.com Staff